↓ Skip to main content

Cochrane Database of Systematic Reviews

Mifepristone for uterine fibroids

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news
1 news outlet
twitter
8 X users
facebook
3 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
249 Mendeley
Title
Mifepristone for uterine fibroids
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd007687.pub2
Pubmed ID
Authors

Mario Tristan, Leonardo J Orozco, Antonia Steed, Anggie Ramirez-Morera, Peter Stone

Abstract

Uterine fibroids are the most common benign uterine tumours present in women of reproductive age. Mifepristone (RU-486) competitively binds and inhibits progesterone receptors. Studies have suggested that fibroid growth depends on the sexual steroids. Mifepristone has been shown to decrease fibroid size. This review summarises the effects of mifepristone treatment on fibroids and the associated adverse effects as described in randomised controlled trials.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 249 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 247 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 17%
Student > Bachelor 29 12%
Researcher 23 9%
Student > Ph. D. Student 20 8%
Student > Postgraduate 17 7%
Other 47 19%
Unknown 70 28%
Readers by discipline Count As %
Medicine and Dentistry 98 39%
Nursing and Health Professions 17 7%
Psychology 11 4%
Biochemistry, Genetics and Molecular Biology 8 3%
Pharmacology, Toxicology and Pharmaceutical Science 8 3%
Other 29 12%
Unknown 78 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2023.
All research outputs
#2,032,754
of 25,388,229 outputs
Outputs from Cochrane database of systematic reviews
#4,348
of 12,797 outputs
Outputs of similar age
#12,656
of 181,881 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 212 outputs
Altmetric has tracked 25,388,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,797 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 212 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.